$BIOCON

**Business Outlook & Global Expansion** **Biocon:** Strengthened its regional supply network through its global manufacturing footprint and is expanding its commercial presence across **France, Portugal, Slovenia and Spain**. The company expects **growth momentum to build progressively through FY27**, with **H2 FY27 expected to be meaningfully stronger**, led by its biosimilars business. **Impact:** **Positive;** global expansion and a strong biosimilars outlook support long-term revenue and earnings growth.